At a glance
ClinicalIndex Comparison RecordN/ACompleted· 177 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 4, Observational Study to Explore How Different Treatment Regimens Affect Continuation With Treatment in the First 6 Months Following Initiation of XAGRID Into Adult Patients' Essential Thrombocythemia Therapy
In Brief
An observational study for Essential Thrombocythemia. Completed, enrolled 177 participants across 46 sites.
Detailed Summary
This is an observational study to explore how different treatment regimens affect continuation with treatment in the first 6 months following initiation of XAGRID into adult patients' essential thrombocythemia therapy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEssential Thrombocythemia
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2010
Enrollment StartSep 2010
Primary CompletionDec 2012
TodayJul 2026
First PostedSep 1, 2010
Enrollment StartSep 13, 2010
Primary CompletionDec 21, 2012
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 15.8 years ago